Evolution of heart transplant donor characteristics in the 21st century: A United States single center’s experience

Figure 1 Key events that have shaped 21^st century donor characteristics. Despite the changing landscape of donor characteristics, national volume of non-traditional donors remains low. HOPE: HIV Organ Policy Equity; HCV Ab: Hepatitis C virus antibody; HIV: Human immunodeficiency virus; DAA: Direct acting antiviral; NAT: Nucleic acid testing; DCD: Donation after cardiac death; COVID: Coronavirus disease.

Figure 2 Evolving single center donor characteristics during the 21^st century. As of 2022, more than half of the transplants performed were from non-traditional donors. HCV Ab: Hepatitis C virus antibody; NAT: Nucleic acid testing; DCD: Donation after cardiac death; LVSD: Left ventricular systolic dysfunction; HIV: Human immunodeficiency virus; COVID: Coronavirus disease.